Gainers in Tuesday’s Trading Session: PHH Corporation (PHH), USEC Inc. (USU), Macquarie Infrastructure Company LLC (MIC), Neurometrix Inc (NURO), TherapeuticsMD Inc (TXMD)

293

By abarnett on July 10, 2014 BioPharma

On July 8, the share prices of PHH Corporation (NYSE:PHH) increased by 4 percent when the company announced its successful sale; PHH Corporation (NYSE:PHH) is a fleet management and mortgage service provider firm. The company’s recent sale was to Element Financial Corporation for a total of $1.4 billion. The company has a market capitalization of $1.39 billion whereas a price earnings ratio of 57.11. As far as company’s beta and EPS go, the figures are reported to be around 1.11 and $0.42 respectively. Moreover, the company has a 52 week range of $20.58 to $27.13.

USEC Inc. (NYSE:USU) stocks, in the past 5 days, have climbed over approximately 120 percent. In the last trading session, the shares of the company opened at $5.67 and closed at an increased price of $6.31, with an average trading volume of 1.22 million shares. The company has a 52 week high of $29.12 and a 52 week low of $2.63. As far as the EPS (earnings per share) of the company is concerned, the figures are reported to have been in a negative value: -$42.39

As soon as the news of Macquarie Infrastructure Company LLC (NYSE:MIC) acquiring 50 percent of the shares of IMTT hit the market, Macquarie saw its new 52-week high at a price of $68.41. Sources have it that the company has sealed the deal with International-Matex Tank Terminals for a total of $1.025 billion. As far as MIC’s market capitalization and price earnings ratio go, the figures are reported to be $3.82 billion and 81 respectively.MIC’s average trading volume is 241,627 shares whereas its EPS is $0.83. Moreover, the company’s dividend yield is reported to be 5.51 percent.

Talking about Neurometrix Inc (NASDAQ:NURO) share prices, the prices jumped up by 35 percent in the last trading session following the release of company’s report that stated that FDA had given its approval for company’s wearable technology. According to the company, this approved technology will be used to treat chronic pain. In the last trading session, company’s intraday range was recorded to be $2.23 to $3.15, with a market capitalization of 1.4 million. As far as company’s beta and EPS figures are concerned, the numbers are reported to lay somewhere on -1.2 and -$2.26 respectively. Moreover, the company has a 52 week high of $4.25 whereas a 52 week low of $1.47.

Coming to TherapeuticsMD Inc (NYSEMKT:TXMD), the company’s share prices jumped up by 17 percent following the release of a research report by FBR Capital Markets. The analysts at FBR gave TherapeuticsMD a rating of ‘Outperform’ with a target price of $34 per share. This report was released on July 8, and the pharmaceutical company’s share prices for the day varied from $4.65 to $5.25. The company’s market capitalization reached the figures of $795.55 million whereas its beta was recorded at 4.94. As far as company’s institutional ownership goes, it holds 65 percent of the company’s shares.